Flexible Flat-Rate Plans

Flat-rate pricing for predictable budgeting

Short-term plans for project- or client-based billing

► Plans and Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 020298

« Back to Dashboard
NDA 020298 describes ALOPRIM, which is a drug marketed by Mylan Institutional and is included in one NDA. It is available from one supplier. Additional details are available on the ALOPRIM profile page.

The generic ingredient in ALOPRIM is allopurinol sodium. There are twenty-one drug master file entries for this compound. Two suppliers are listed for this compound. Additional details are available on the allopurinol sodium profile page.

Summary for NDA: 020298

Mylan Institutional
allopurinol sodium
Formulation / Manufacturing:see details

Pharmacology for NDA: 020298

Mechanism of ActionXanthine Oxidase Inhibitors

Suppliers and Packaging for NDA: 020298

Tradename Generic Name Dosage NDA Application Type Supplier National Drug Code Package Code Package
allopurinol sodium
INJECTABLE;INJECTION 020298 NDA Mylan Institutional LLC 67457-187 67457-187-50 1 VIAL, GLASS in 1 CARTON (67457-187-50) > 25 mL in 1 VIAL, GLASS

Summary for product number 001

Active Rx/OTC/Discontinued:RXDosage:INJECTABLE;INJECTIONStrengthEQ 500MG BASE/VIAL
Approval Date:May 17, 1996TE:APRLD:Yes

Complete Access Available with Subscription
« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.